Home / Sweden / Active Biotech AB
Active Biotech AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
78 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Active Biotech AB by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| October 5, 2014 | OrbiMed Advisors LLC | 1.40% | |
| September 25, 2014 | OrbiMed Advisors LLC | 1.30% | |
| September 24, 2014 | OrbiMed Advisors LLC | 1.22% | |
| September 23, 2014 | OrbiMed Advisors LLC | 1.22% | |
| September 17, 2014 | OrbiMed Advisors LLC | 1.01% | |
| September 16, 2014 | OrbiMed Advisors LLC | 1.01% | |
| September 12, 2014 | OrbiMed Advisors LLC | 0.90% | |
| September 11, 2014 | OrbiMed Advisors LLC | 0.90% | |
| September 10, 2014 | OrbiMed Advisors LLC | 0.80% | |
| September 9, 2014 | OrbiMed Advisors LLC | 0.80% | |
| September 5, 2014 | OrbiMed Advisors LLC | 0.75% | |
| September 4, 2014 | OrbiMed Advisors LLC | 0.75% | |
| September 2, 2014 | OrbiMed Advisors LLC | 0.63% | |
| September 1, 2014 | OrbiMed Advisors LLC | 0.63% | |
| July 21, 2014 | GSA Capital Partners LLP | 0.69% | |
| July 20, 2014 | GSA Capital Partners LLP | 0.69% | |
| July 2, 2014 | GSA Capital Partners LLP | 0.70% | |
| July 1, 2014 | GSA Capital Partners LLP | 0.70% | |
| May 5, 2014 | GSA Capital Partners LLP | 0.60% | |
| May 4, 2014 | GSA Capital Partners LLP | 0.60% | |
| March 25, 2014 | GSA Capital Partners LLP | 0.50% | |
| March 24, 2014 | GSA Capital Partners LLP | 0.50% | |
| January 30, 2013 | Oxford Asset Management | 0.59% | |
| January 29, 2013 | Oxford Asset Management | 0.59% | |
| December 14, 2012 | Oxford Asset Management | 0.69% | |
| December 13, 2012 | Oxford Asset Management | 0.69% | |
| November 2, 2012 | Oxford Asset Management | 0.79% | |
| November 1, 2012 | Oxford Asset Management | 0.79% |
Download 78 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
- Elekta AB (publ) 8.98% of the capital sold short
- JM AB 7.61% of the capital sold short
- Truecaller AB 6.87% of the capital sold short
- Bonesupport Holding AB 6.80% of the capital sold short
- Hemnet Group AB (publ) 6.13% of the capital sold short
- RaySearch Laboratories AB (publ) 4.96% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Aktiebolaget Electrolux 4.41% of the capital sold short
- AAK AB (publ) 4.31% of the capital sold short
- Dynavox Group AB 3.88% of the capital sold short
- Hexatronic Group AB 3.69% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Active Biotech AB, source Finansinspektionen, data as at May 15, 2018, https://www.quivad.com/action/active-biotech-ab?page=2